{"url_path":"/sec/aspi/8-k/2026-07-21/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-21","source_url":"https://www.sec.gov/Archives/edgar/data/1921865/0001193125-26-309573-index.html","accession_number":"0001193125-26-309573","cik":"0001921865","ticker":"ASPI","issuer_name":"ASP Isotopes Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1921865/0001193125-26-309573-index.html","primary_entity_key":"0001921865","primary_entity_name":"ASP Isotopes Inc."},"word_count":190,"has_tables":true,"body_markdown":"## Item 7.01 Regulation FD Disclosure.\n\nOn July 21, 2026, ASP Isotopes Inc. (the “Company”) issued a press release regarding a research agreement with the Texas A&M Engineering Experiment Station (TEES) to advance and de-risk the commercial production of high-purity uranium hexafluoride (UF6), a critical feedstock in the existing nuclear fuel enrichment supply chain, which is attached hereto as Exhibit 99.1 and is incorporated by reference herein (the “Press Release”).\n\n \n\nThe information in this Item 7.01 and in the Press Release shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, and shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission, whether made by the Company before or after the date hereof, regardless of any general incorporation language in such\n\nfiling.\n\n \n\nThe Press Release includes “safe harbor” language pursuant to the Private Securities Litigation Reform Act of 1995, as amended, indicating that certain statements contained therein are “forward-looking” rather than historical."}